Achieve Life Sciences Inc (SP4P) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.337x

Based on the latest financial reports, Achieve Life Sciences Inc (SP4P) has a cash flow conversion efficiency ratio of -0.337x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-11.33 Million ≈ $-13.25 Million USD) by net assets (€33.62 Million ≈ $39.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Achieve Life Sciences Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Achieve Life Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Achieve Life Sciences Inc (SP4P) total liabilities for a breakdown of total debt and financial obligations.

Achieve Life Sciences Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Achieve Life Sciences Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CCK Consolidated Holdings Bhd KLSE:7035	0.024x
Acrow Ltd AU:ACF	0.074x
Zinus Inc KO:013890	0.131x
Sailfish Royalty Corp V:FISH	0.020x
Virgin Galactic Holdings Inc NYSE:SPCE	-0.249x
Grand Fortune Securities Co Ltd TWO:6026	-0.003x
DingZing Advanced Materials Inc. TW:6585	0.008x
Hanmiglobal KO:053690	-0.005x

Annual Cash Flow Conversion Efficiency for Achieve Life Sciences Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of Achieve Life Sciences Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see SP4P market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€20.90 Million ≈ $24.43 Million	€-29.77 Million ≈ $-34.80 Million	-1.424x	-108.43%
2023-12-31	€-1.45 Million ≈ $-1.69 Million	€-24.48 Million ≈ $-28.62 Million	16.905x	+473.82%
2022-12-31	€8.30 Million ≈ $9.71 Million	€-37.55 Million ≈ $-43.90 Million	-4.522x	-330.76%
2021-12-31	€28.04 Million ≈ $32.78 Million	€-29.44 Million ≈ $-34.42 Million	-1.050x	-190.52%
2020-12-31	€37.29 Million ≈ $43.59 Million	€-13.47 Million ≈ $-15.75 Million	-0.361x	+57.13%
2019-12-31	€18.05 Million ≈ $21.10 Million	€-15.22 Million ≈ $-17.79 Million	-0.843x	-25.40%
2018-12-31	€15.80 Million ≈ $18.47 Million	€-10.62 Million ≈ $-12.42 Million	-0.672x	+41.84%
2017-12-31	€7.88 Million ≈ $9.21 Million	€-9.11 Million ≈ $-10.65 Million	-1.156x	-10752.47%
2016-12-31	€18.97 Million ≈ $22.17 Million	€-202.00K ≈ $-236.16K	-0.011x	--

About Achieve Life Sciences Inc

F:SP4P Germany Biotechnology

Market Cap

$224.05 Million

€191.64 Million EUR

Market Cap Rank

#16705 Global

#1578 in Germany

Share Price

€3.60

Change (1 day)

+0.56%

52-Week Range

€1.79 - €4.91

All Time High

€5709.00